P539: A PHASE 1 STUDY OF HMPL-306, A DUAL INHIBITOR OF MUTANT ISOCITRATE DEHYDROGENASE (IDH) 1 AND 2, IN PTS WITH RELAPSED/REFRACTORY MYELOID HEMATOLOGICAL MALIGNANCIES HARBORING IDH1 AND/OR 2 MUTATIONS
P539：HMPL-306（一种突变异柠檬酸脱氢酶 (IDH) 1 和 2 的双重抑制剂）在携带 IDH1 和/或 2 突变的复发/难治性髓系血液恶性肿瘤患者中的 1 期研究
期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms24021213
Kanwal, Simab; De-Eknamkul, Wanchai; Hu, Lijuan; Zhao, Wei-LI; Wu, Wen; Wei, Xudong; MI, Ruihua; Hu, Yu; LI, Qiubai; He, Wenjuan; LI, Juan; Dong, Yugang; Wang, Hehua; Zhang, Xuhan; Zhang, Yu; Xu, Zhongyuan; Liu, Hui; Cai, Zhen; Sun, Jie; Xu, Yajing; Jiang, Zhiping; Zhang, Cheng; Chen, Guo; Gong, Tiejun; Tang, Qinghua; Jing, Hongmei; MA, Lan; Gao, Sujun; Liu, Qiqi; Zhong, Zeyu; Ren, Yongxin; Chen, Jian; Fan, Songhua; Shi, Michael; Su, Weiguo; Huang, Xiaojun
